Business Weekly

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

With 65% of American adults now playing video games, how can investors get in on the game as well?

In this episode JP Lee, ETF product manager at VanEck explains the recent growth and his expectations for the industry after lockdowns. He also discusses some of the bigg ...

In January 2022, Microsoft announced its acquisition of the video game company Activision Blizzard for $68.7 billion. The deal would make Microsoft the world’s third largest video game company, but it also exposes the company to several risks. First, the all-cash deal would requi ...  Show more

Nearly two years after the initial announcement, Microsoft has completed the largest deal in tech history.  (00:21) Ricky Mulvey and Asit Sharma discuss: - What got Microsoft across the finish line for its acquisition of Activision Blizzard. - An unexpected winner in the deal. - ...  Show more

**FIRST EPISODE - WEDNESDAY 30TH AUGUST** Does money really make the world go round? Economics, business and finance have long been subjects we leave to the stock brokers, hedge fund managers and business school professors who spend their lives obsessing over them - but there’s ...  Show more